Overview
bit.bio is a synthetic biology company providing human iPSC-derived cells for research, drug discovery, and cell therapy applications. They utilize patented opti-ox™ technology to deterministically reprogram stem cells into consistent, scalable cell types such as neurons, immune cells, and muscle cells under the ioCells brand. Their platform supports neurodegeneration, neurophysiology, and disease modeling with reliable, high-quality human cells.
Frequently asked questions
- What cell types does bit.bio offer?
- bit.bio offers human iPSC-derived neurons (including glutamatergic, GABAergic, and motor neurons), immune cells, muscle cells, and disease models under the ioCells brand for research and drug discovery.
- What is bit.bio's core technology?
- bit.bio's opti-ox™ technology enables deterministic, precise reprogramming of human iPSCs into defined cell types using inducible transcription factors discovered via their genetic screening and machine learning platform.
- What are the applications of bit.bio's products?
- Products support neurodegeneration, neurophysiology, neurodevelopmental research, drug discovery, and cell therapy with consistent, scalable human cells to reduce experimental variance.